These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

In patients with psoriasis receiving immunomodulatory therapy, some immune responses to COVID-19 vaccination were positive whereas others were not.

The research collaboration will explore new avenues and innovative solutions for treatment of skin diseases, opening ...

Psoriasis is a common and chronic skin condition that shows up as red, itchy, and scaly patches, often on areas like the ...

Psoriasis is a skin disease where the immune system overreacts, leading to patches of inflamed, scaly skin. These patches ...

Psoriasis is a multifactorial immune-mediated inflammatory disease. Its pathogenesis involves abnormal accumulation of neutrophils and T-cell related abnormalities. Pyroptosis is a type of regulated ...

Dermatologists recently have developed and validated several tools for assessing itch in plaque psoriasis, such as the Peak ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

La La Anthony took to Instagram to share her personal struggle with plaque psoriasis, a chronic autoimmune condition that ...

In an exclusive interview, La La Anthony discusses her 10-year battle with plaque psoriasis, the autoimmune disease that ...

Called psoriatic arthritis, or PsA, it frequently stems from a non-communicable skin disease named psoriasis, which causes skin cells to grow faster than usual and results in itchy and scaly patches ...